Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no single official Wegovy meal plan PDF — but there is a clear body of nutritional guidance around what eating patterns tend to support semaglutide treatment. The medicine reduces appetite significantly, so the real dietary decision is not how much to restrict, but how to use a smaller appetite well: getting enough protein, fibre, and fluid from less food. Wegovy (semaglutide) is a prescription-only medicine licensed in the UK for weight management, and any meal plan works alongside (not instead of) clinical supervision. What you eat matters for how well you feel on treatment and for whether the weight you lose is mostly fat rather than muscle.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The appeal of a downloadable meal plan is understandable. When appetite drops and food decisions feel complicated, having a sheet on the fridge door that simply tells you what to eat on Monday feels like relief. The problem is that a generic PDF cannot account for the things that actually shape your dietary needs: your starting weight, your activity level, whether you have type 2 diabetes or other conditions, and how your gut is tolerating the medicine at this particular dose.
What the evidence does offer is a set of consistent principles. Research into reduced-calorie diets alongside GLP-1 medicines, including the trial populations in the STEP programme, points to the same pattern: people do better when their reduced intake is built around protein and fibre rather than around cutting any one food group entirely. The full Wegovy treatment guide covers how semaglutide works on appetite; here, the focus is the food side of that equation.
A practical starting point is to plan three smaller meals with a reliable protein source at each one (eggs, fish, chicken, legumes, Greek yoghurt) and to treat high-fat, high-sugar foods as things to reduce gradually rather than eliminate overnight, partly because fatty meals can worsen nausea in the early weeks. That is not a prescription; it is a framework you adapt with your prescriber or a registered dietitian.
One of the quieter risks of effective appetite suppression is that people eat so little they fall short of protein, iron, B vitamins, and calcium, nutrients that matter for energy, muscle, and bone. This is the reason the NHS guidance on weight-management medicines sits alongside advice to eat a varied, balanced diet rather than simply eat less. The NHS England overview of weight-management injections is explicit that lifestyle support, including dietary guidance, should accompany treatment.
Protein is the most commonly discussed shortfall. General guidance for adults managing weight with a GLP-1 medicine points toward at least 1.2–1.6 g of protein per kilogram of body weight per day, though the right figure for any individual depends on body composition and activity. Spreading protein across meals (rather than concentrating it in one sitting) makes it easier for the body to use. A palm-sized portion of protein at breakfast, lunch, and dinner is a reasonable practical rule.
Fibre matters too, both for gut health and satiety. Vegetables, legumes, oats, and whole grains are the most practical sources. They also tend to be lower in calorie density, which means more food volume from fewer calories, useful when the goal is adequate nutrition from a smaller eating window. Hydration deserves a mention here: nausea and reduced appetite sometimes lead people to drink less, and mild dehydration amplifies fatigue and headaches that can already accompany the early weeks of treatment. Aiming for six to eight glasses of water daily is a simple target to keep visible.
Rather than a rigid plan, most people on Wegovy find that a loose template holds better than a strict schedule. Three meals, consistent times where possible, each anchored by protein. The portion size adjusts itself because appetite is genuinely lower, the challenge is making sure that smaller portion still contains what the body needs.
Breakfast might be two eggs with wholegrain toast and a handful of spinach; lunch a tin of fish or a portion of lentil soup with some rye bread; dinner a palm of chicken or tofu with roasted vegetables and a small portion of rice or potatoes. These are not prescriptive, they illustrate how relatively ordinary food choices can cover the nutritional bases without the complexity of a bespoke plan.
The foods that frequently cause problems on semaglutide are high-fat meals (particularly very rich or fried foods), large volumes of food eaten quickly, and fizzy drinks, which can worsen bloating. Alcohol deserves careful consideration too: it adds calories and can interact unpredictably with reduced food intake. For a deeper look at which foods tend to sit better during treatment, the guide on what to eat on Wegovy covers the practicalities in more detail.
The question of cost sometimes arises alongside dietary planning, people reasonably wonder whether the expense of the medicine makes spending more on food difficult. The treatment options page covers what is included in private prescribing at nume, including aftercare where these questions come up. On the dietary side specifically, putting together a Wegovy meal plan that works for you does not require expensive supplements or specialist products. Most of what helps (eggs, lentils, vegetables, oats) is affordable.
A PDF is a starting point, not a substitute for clinical support. If you are losing weight faster than expected, eating very little without feeling unwell, or struggling with persistent nausea that is affecting your nutrition, those are conversations for a prescriber. Rapid unintentional muscle loss, hair thinning, or ongoing fatigue can be signs that intake has dropped too far.
People with type 2 diabetes on semaglutide need to be especially careful about carbohydrate choices and blood glucose monitoring, dietary changes that affect glucose need to be made with clinical oversight, not from a general guide. The same applies to anyone with a history of disordered eating: a rigid meal plan can be counterproductive, and the Beat eating disorders helpline is a resource worth knowing about if food rules feel like they are becoming a source of distress rather than support.
Printed plans and apps can be genuinely useful as prompts. The most helpful approach is to use them flexibly, check them against the principles above (protein, fibre, variety, fluid) and revisit with your clinical team if anything is not working. The meal planning while on Wegovy page goes further on adapting eating patterns as doses change. And if you are considering semaglutide treatment but have not yet started, our semaglutide meal plan PDF brings together what the clinical literature says about diet alongside GLP-1 medicines in a format you can save and refer back to, and the dedicated guide on what your meal plan should look like when you are on Wegovy offers further detail on putting those principles into everyday practice.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.